Epstein Secrets

nomination. Democrats "refused to show up in protest of the GOP's rush to install [President] Trump's nominee. ... Never has the Senate confirmed a Supreme Court nominee so close to a presidential election." The Democrats "displayed posters at their desks of Americans they say have benefited from the Affordab

) reports that Joe Biden, in an interview with CBS' "60 Minutes" that has not yet aired, said he "won't rule out studying the addition of members to the U.S. Supreme Court as part of a commission he plans to name to look at court reforms if he's elected." Bloomberg (10/22, Benjaminson, 4.73M) reports Biden "says he wou

ard, not the relatively low bar used this year for emergency use authorization for treatments." Calling the meeting "an usual step," the AP (10/22, Neergaard, Perrone) reports Dr. Marion Gruber, director of FDA's vaccine research office, told the advisers that public scrutiny "is critical to build trust

2) reports that Joe Biden, in an interview with CBS"160 Minutes" that has not yet aired, said he "won't rule out studying the addition of members to the U.S. Supreme Court as part of a commission he plans to name to look at court reforms if he's elected "Jilnnmberg (10/22, Benjaminson, 4.73M) reports Biden "says he wo

ard, not the relatively low bar used this year for emergency use authorization for treatments." Calling the meeting "an usual step," the AE (10/22, Neergaard, Perrone) reports Dr. Marion Gruber, director of FDA's vaccine research office, told the advisers that public scrutiny "is critical to build trust

reports that Joe Biden, in an interview with CBS' "60 Minutes" that has not yet aired, said he "won't rule out studying the addition of members to the U.S. Supreme Court as part of a commission he plans to name to look at court reforms if he's elected." Bloomberg <https://www.bloomberg.com/news/articles/2020-10-22/bi

for treatments." Calling the meeting "an usual step," the AP <https://apnews.corn/article/virus-outbreak- e49203f5c55ba593ca587a56d0116b97> (10/22, Neergaard, Perrone) reports Dr. Marion Gruber, director of FDA's vaccine research office, told the advisers that public scrutiny "is critical to build trust a